The SUSTAIN-6 study [20], which evaluated the long-term cardiovascular effects of semaglutide sc., in subjects with type 2 diabetes and HbA1c 7%, treated with up to two oral hypoglycaemic agents, with or without basal or premixed insulin, [n = 3297 patients, 50 years with established cardiovascular disease (coronary event, cerebrovascular event, or peripheral vascular disease), chronic kidney disease stage 3, or New York Heart Association class II or III chronic heart failure or 60 years with at least one CVRF)], found a significant reduction in the primary endpoint of MACE appearance by 26% (6.6% vs
It may also improve sleep when those symptoms interfere with rest
Receptor-Target Mismatch GHK-Cu acts primarily on dermal fibroblasts and basal keratinocytes
Clinical Evidence: Study Outcomes and Realistic Expectations Clinical research on both compounds remains limited compared to pharmaceutical-grade biologics
Por eso, aunque pertenecen a la misma familia, se suelen usar en contextos diferentes